乙肝肝硬化患者的抗病毒治疗1课件.ppt

1、1.Fattovich G et al. Hepatology 1995 2. Ikeda K et al. J Hepatol 1998.Jong Ryul Eun et al. AASLD 2 007, abstract 961 32.4% 4.5% （年）（年） Control (n=111) FY YAO et al，Journal of Hepatology 2000; 33: 301-307 Liaw Y-F, Leung N, Guan R et al. . Liver Int 2005: 25; 472-489. LiawYF, Sung JJY,Chow WC,et al.

2、N Engl J Med 2004;351: 1521-31.Liaw Y-F, Leung N, Guan R et al. . Liver Int 2005: 25; 472-489.LiawYF, Sung JJY,Chow WC,et al. N Engl J Med 2004;351: 1521-31.De Jongh et al. Gastroenterology. 1992;103:1630.* 慢性乙型肝炎防治指南APASLPerrillo et al 1999Perrillo et al， Hepatology 2001; 33: 424Kapoor et al. J Hep

3、atol 2000; 33: 308-312FY YAO, Hepatology ，2001 ，34 :411-416.Mahmood Yousefi-Mashhour, Hepatitis Monthly 2007;7(2):77-81Kapoor et al. J Hepatol 2000; 33: 308-312Perrillo Journal of Hepatology 39 (2003) S177S180* De Jongh et al. Gastroenterology. 1992;103:1630.53%76%80%10%0%10%20%30%40%50%60%70%80%90%

4、移植后复发率5年生存率百分比(%)未进行抗病毒抗病毒药物+HBIGBijal Surti,et al ，Current Hepatitis Reports 2008， 7:2532Kappor et al.Journal of Hepatology 2000; 33: 308-312Perrillo et al, Hepatology 2001; 33: 424-432Villeneuve et al. HEPATOLOGY. 2000;31:207-210.Spilios et al. The American Journal of Gastroenterology (2003) 99, 5763Liaw YF et al.N Engl J Med 2004;351:1521-31.1.Lok AS， Lai CL， Leung N， et al. Gastroenterology. 2003 Dec;125(6):1714-22.2.Liaw Y-F， Leung N， Guan R et al. . Liver Int 2005: 25; 472-489. :3.APASL 2008 * 中国慢乙肝指南 谢谢！